CHARLESTON — There was nothing unusual or illegal about how pharmaceutical manufacturers distributed prescription opioids, attorneys for the companies argued Monday.
CHARLESTON — Lawyers for pharmaceutical distributors presented video depositions Friday demonstrating what the companies describe as weaknesses in federal systems to detect and stop suspicious opioid orders.
CHARLESTON — The state of West Virginia concluded its arguments Thursday in its case against two pharmaceutical companies it has accused of using deceptive practices that helped fuel the opioid
CHARLESTON — Pharmaceutical manufacturers followed the letter of the law of the federal Controlled Substances Act, but didn’t act in the spirit of the law when it came to keeping
CHARLESTON — Dr. Matthew Christiansen, head of the West Virginia Office of Drug Control Policy, took the stand Friday in the state’s ongoing opioid trial to explain how the addiction